A prospective, randomized, parallel group, double blind, multicenter study to compare the efficacy, safety and immunogenicity of Lupin’s Ranibizumab with Lucentis® in patients with neovascular age-related macular degeneration

Singh, Ramandeep; Chauhan, Rohan; Saxena, Ashish; Shah, Anup; Mondal, Laxshmi; Bakhle, Dhananjay; Shah, Chirag; Shah, Arpit; Deoghare, Shashank; Krishnan, Neelakant; Godse, Neelima

Singh, Ramandeep; Chauhan, Rohan; Saxena, Ashish; Shah, Anup; Mondal, Laxshmi; Bakhle, Dhananjay; Shah, Chirag; Shah, Arpit; Deoghare, Shashank; Krishnan, Neelakant; Godse, Neelima.

Indian J Ophthalmol ; 2022 Aug; 70(8): 3008-3014

Article | IMSEAR | ID: sea-224532